Полсар

Полсар (Ticagrelor) is an antiplatelet medication used to prevent blood clots after heart-related events. It belongs to the P2Y12 inhibitor class, supporting cardiovascular health. This oral treatment is prescribed for patients with acute coronary syndromes or a history of heart attacks. Always consult a healthcare provider before use.

Ticagrelor is prescribed to reduce the risk of blood clots forming in arteries, which can lead to heart attacks or strokes. It is commonly used after a heart attack or in patients with unstable angina. Ticagrelor works by preventing platelets in the blood from sticking together. This medication is often taken alongside low-dose aspirin for enhanced effectiveness in cardiovascular protection.

Ticagrelor helps maintain healthy blood flow by reducing the likelihood of dangerous clots. Users may experience improved circulation and reduced strain on the heart. Some people report feeling more energetic as their cardiovascular system functions more efficiently. Regular use supports long-term heart health and reduces the risk of recurrent cardiac events.

Ticagrelor should be taken exactly as prescribed by a healthcare professional. Avoid sudden changes in dosage without medical guidance. Inform your doctor about any bleeding disorders or upcoming surgeries, as Ticagrelor affects blood clotting. Keep this medication in a secure place, away from children. Report any unusual bruising or bleeding immediately.

Ticagrelor may interact with other blood thinners, NSAIDs, or certain antidepressants, increasing bleeding risk. Avoid grapefruit products, as they can alter how Ticagrelor is metabolized. Alcohol consumption should be limited, as it may enhance side effects like dizziness. Always disclose all medications and supplements to your doctor before starting Ticagrelor.